Landos Biopharma, Inc. (LABP) Earnings
|
Expand Research on LABP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +49.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/23  |
Q223 | -$0.63 | -$1.07 | +$0.44 | N/A | N/A | N/A |  | | Details | |
| 5/11/23 | Q123 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/23 | Q422 | -$0.13 | -$0.19 | +$0.06 | N/A | N/A | N/A | | | Details | |
| 11/10/22 | Q322 | -$0.32 | -$0.28 | -$0.04 | N/A | N/A | N/A | | | Details | |
| 8/11/22 | Q222 | $0.12 | -$0.32 | +$0.44 | $18M | N/A | N/A | | | Details | |
| 8/11/22 | Q222 | $0.12 | -$0.33 | +$0.45 | $18M | N/A | N/A | | | Details | |
| 8/11/22 | Q222 | $0.12 | -$0.33 | +$0.45 | $18M | N/A | N/A | | | Details |
